Evidence map›Paper›PMID 41463201›Full record

ArticleCancers2025

Perceptions and Expectations of Pharmacist Interventions in Adverse Event Management During Drug Therapy for Metastatic Renal Cell Carcinoma: A Cross-Sectional Survey in Japan.

Tetsuya Wako, Go Kimura, Yasuhisa Fujii, Takahiro Osawa, Yosuke Uchitomi, Kazunori Honda, Miki Kondo, Ariko Otani, Yoshihide Mitsuda, Nobuo Shinohara

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tetsuya WakoDepartment of Pharmacy, Nippon Medical School Musashikosugi Hospital, Kawasaki 211-8533, Japan.
Go KimuraDepartment of Urology, Nippon Medical School Hospital, Tokyo 113-8603, Japan.ORCID 0000-0003-0088-9324
Yasuhisa FujiiDepartment of Urology, Institute of Science Tokyo, Tokyo 113-8510, Japan.
Takahiro OsawaDepartment of Urology, Hokkaido University Hospital, Sapporo 060-8638, Japan.
Yosuke UchitomiDepartment of Cancer Survivorship and Digital Medicine, The Jikei University School of Medicine, Tokyo 105-8461, Japan.
Kazunori HondaDepartment of Clinical Oncology, Aichi Cancer Center, Nagoya 464-8681, Japan.ORCID 0000-0001-5090-9771
Miki KondoDepartment of Nursing, National Cancer Center Hospital East, Kashiwa 277-8577, Japan.
Ariko OtaniDepartment of Nursing, National Cancer Center Hospital East, Kashiwa 277-8577, Japan.
Yoshihide MitsudaEisai Co., Ltd., Tokyo 112-8088, Japan.
Nobuo ShinoharaDepartment of Urology, Kushiro Rosai Hospital, Kushiro 085-0052, Japan.

Funding

Eisai (Japan) N/A
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adverse eventcross-sectional surveymultidisciplinary managementperceptionspharmacistrenal cell carcinoma

Identifiers

PMID41463201
PMCPMC12731063

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.